Fortress Biotech, Inc. Financial Ratios
FBIO|FY2025 SEC 10-K data
Includes DuPont ROE decomposition, profitability margins, liquidity ratios, solvency indicators, and earnings quality analysis. All ratios calculated from FY2025 SEC 10-K data.
Key Data Points
- Altman Z-Score -1.10 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
DuPont ROE Decomposition (FY2025)
Return on Equity
-92.2%
Profit Margin
-79.8%
Net Income / Revenue
Asset Turnover
0.31
Revenue / Total Assets
Equity Multiplier
3.72
Total Assets / Equity
Composite: -92.2% (reported: -92.2%)
Profitability
Liquidity
Current Ratio
2.49
Quick Ratio
2.30
Solvency
Interest Coverage
-5.93
Efficiency
Asset Turnover
0.31
Inventory Turnover
2.17
Days Sales Outstanding
188 days
As of FY2025 · SEC 10-K · Updated Jun 28, 2026
Earnings Quality
Accrual Ratio
+20.7%
-26.1pp YoY
Earnings include a notable portion of accrual components.
This metric is for informational purposes only and does not constitute investment advice. Data sourced from SEC EDGAR filings; updates may be delayed.